BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27679560)

  • 1. Growth Hormone Control of Hepatic Lipid Metabolism.
    Liu Z; Cordoba-Chacon J; Kineman RD; Cronstein BN; Muzumdar R; Gong Z; Werner H; Yakar S
    Diabetes; 2016 Dec; 65(12):3598-3609. PubMed ID: 27679560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.
    Fan Y; Menon RK; Cohen P; Hwang D; Clemens T; DiGirolamo DJ; Kopchick JJ; Le Roith D; Trucco M; Sperling MA
    J Biol Chem; 2009 Jul; 284(30):19937-44. PubMed ID: 19460757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.
    Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J
    Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of reduced growth hormone action in fatty liver disease.
    Rufinatscha K; Ress C; Folie S; Haas S; Salzmann K; Moser P; Dobner J; Weiss G; Iruzubieta P; Arias-Loste MT; Crespo J; Tilg H; Kaser S
    Hepatol Int; 2018 Sep; 12(5):474-481. PubMed ID: 30206761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolving the growth-promoting and metabolic effects of growth hormone: Differential regulation of GH-IGF-I system components.
    Norbeck LA; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2007 May; 151(3):332-41. PubMed ID: 17376444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice.
    Cordoba-Chacon J; Majumdar N; List EO; Diaz-Ruiz A; Frank SJ; Manzano A; Bartrons R; Puchowicz M; Kopchick JJ; Kineman RD
    Diabetes; 2015 Sep; 64(9):3093-103. PubMed ID: 26015548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E; Velasco B; Barrios R; Sanchez-Franco F
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats.
    Bielohuby M; Sawitzky M; Stoehr BJ; Stock P; Menhofer D; Ebensing S; Bjerre M; Frystyk J; Binder G; Strasburger C; Wu Z; Christ B; Hoeflich A; Bidlingmaier M
    Endocrinology; 2011 May; 152(5):1948-60. PubMed ID: 21427215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis.
    Venken K; Schuit F; Van Lommel L; Tsukamoto K; Kopchick JJ; Coschigano K; Ohlsson C; Movérare S; Boonen S; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.
    Sarmento-Cabral A; Del Rio-Moreno M; Vazquez-Borrego MC; Mahmood M; Gutierrez-Casado E; Pelke N; Guzman G; Subbaiah PV; Cordoba-Chacon J; Yakar S; Kineman RD
    J Endocrinol; 2021 Jan; 248(1):31-44. PubMed ID: 33112796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of growth hormone (GH) to adult chickens exerts marked effects on circulating concentrations of insulin-like growth factor-I (IGF-I), IGF binding proteins, hepatic GH regulated gene I, and hepatic GH receptor mRNA.
    Radecki SV; McCann-Levorse L; Agarwal SK; Burnside J; Proudman JA; Scanes CG
    Endocrine; 1997 Apr; 6(2):117-24. PubMed ID: 9225125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the Isolated and Combined Ablation of Growth Hormone and IGF-1 Receptors in Somatostatin Neurons.
    Chaves FM; Wasinski F; Tavares MR; Mansano NS; Frazao R; Gusmao DO; Quaresma PGF; Pedroso JAB; Elias CF; List EO; Kopchick JJ; Szawka RE; Donato J
    Endocrinology; 2022 May; 163(5):. PubMed ID: 35395079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
    Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
    Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral nutrition with lipid or glucose suppresses liver growth and response to GH in adolescent male rats.
    Sevette A; Kee AJ; Carlsson AR; Baxter RC; Smith RC
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1063-72. PubMed ID: 11595664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β.
    Zhao Y; Xiao X; Frank SJ; Lin HY; Xia Y
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E186-98. PubMed ID: 24895283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles.
    List EO; Berryman DE; Funk K; Jara A; Kelder B; Wang F; Stout MB; Zhi X; Sun L; White TA; LeBrasseur NK; Pirtskhalava T; Tchkonia T; Jensen EA; Zhang W; Masternak MM; Kirkland JL; Miller RA; Bartke A; Kopchick JJ
    Endocrinology; 2014 May; 155(5):1793-805. PubMed ID: 24517230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.